I think the point is that the US pays for all the research into life saving medications and/or treatments and so the cost of said research is passed on to US consumers but other countries like Germany aren't subject to the US patent system and can just make and sell whatever drugs they want using the research bought and payed for by US consumers as assurance that said drugs are safe.
So pharmaceutical companies have no leverage to get consumers in countries like Germany to pay their share for said research.
So, the US is trying to incentivize their "allies" to pay their share for this.
•
u/vixxienz 10h ago
there was pressure on Pharmac here also ( new zealand)